TrialDiabetes, obesity & metabolism2026

Multi-Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial.

Ruth P Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.